Ewayan, Mina .

HRN: 08-03-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2025
AMPICILLIN 1GM (VIAL)
07/04/2025
07/11/2025
IV
2g
Q6h
Thinly MSAF
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: